Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe ; volume:12 ; number:1 ; day:4 ; month:2 ; year:2013 ; pages:1-9 ; date:12.2013
Lipids in health and disease ; 12, Heft 1 (4.2.2013), 1-9, 12.2013
- Creator
-
Yamazaki, Daisuke
- Contributor
-
Ishida, Masaru
Watanabe, Hiroyuki
Nobori, Kiyoshi
Oguma, Yasunori
Terata, Yutaka
Koyama, Takashi
Iino, Kenji
Kosaka, Toshimitsu
Itō, Hiroshi
SpringerLink (Online service)
- DOI
-
10.1186/1476-511X-12-9
- URN
-
urn:nbn:de:1111-2016061014490
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yamazaki, Daisuke
- Ishida, Masaru
- Watanabe, Hiroyuki
- Nobori, Kiyoshi
- Oguma, Yasunori
- Terata, Yutaka
- Koyama, Takashi
- Iino, Kenji
- Kosaka, Toshimitsu
- Itō, Hiroshi
- SpringerLink (Online service)
Other Objects (12)
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Aktivierung der erythrozytären NO-Synthase durch Rosuvastatin
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
Rosuvastatin cocrystals: an attempt to modulate physicochemical parameters
An efficient approach to the key intermediate of rosuvastatin
β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Aktivierung der erythrozytären NO-Synthase durch Rosuvastatin
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
Rosuvastatin cocrystals: an attempt to modulate physicochemical parameters
An efficient approach to the key intermediate of rosuvastatin
β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patients
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Aktivierung der erythrozytären NO-Synthase durch Rosuvastatin
Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes
Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
Rosuvastatin cocrystals: an attempt to modulate physicochemical parameters
An efficient approach to the key intermediate of rosuvastatin
β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats
Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report